安諾倫（北京）生物科技有限公司是一家創(chuàng)辦于2015年的創(chuàng)新型高科技企業(yè)，公司由在國內(nèi)科研試劑領(lǐng)域有著十幾年從業(yè)經(jīng)驗(yàn)的專業(yè)技術(shù)團(tuán)隊(duì)和企業(yè)管理團(tuán)隊(duì)組建而成，專門從事以抗體、蛋白、細(xì)胞、化學(xué)品為核心的試劑產(chǎn)品研發(fā)與銷售。擁有國內(nèi)外數(shù)百家品牌試劑代理權(quán)，為眾多需求客戶及科研機(jī)構(gòu)提供品質(zhì)保障、價格合理和操作便捷的品牌試劑。

HMGBiotech品牌代理

      HMGB 1是細(xì)胞核的一個組成部分，在基因組的組織和表達(dá)中具有多種功能。HMG生物技術(shù)SRL為活躍在這一領(lǐng)域的其他研究人員和公司提供試劑、服務(wù)和想法。它還有助于比安奇實(shí)驗(yàn)室開發(fā)分析和試劑。

HMGB1 is a component of the cell nucleus, with multiple functions in the organization and expression of the genome. When a cell dies because of an insult (a virus, a mechanical or chemical trauma, poisoning) HMGB1 is released and is picked up by receptors in nearby cells. In addition, cells under severe stress secrete HMGB1 even before dying. Surviving cells mount a firstline response -inflammation- and try to replace the dead cells and reconstruct the damaged tissue. HMGB1 promotes recovery and regeneration, for example of the heart after infarction. However, too much HMGB1 is associated to sepsis (excessive inflammation leading to acute distress and eventually death), arthritis, atherosclerosis, and cancer metastasis.

產(chǎn)品列表：